Vireo Growth reports Q1 EPS (2c) vs. (5c) last year

Reports Q1 revenue $24.5M vs. $24.1M last year. CEO John Mazarakis commented, “First quarter results were in line with our expectations for Vireo’s established markets. We experienced continued growth in Maryland, stable performance in Minnesota, medical sales declines in New York, and the commencement of New York adult use sales from our indoor facility. We remain focused on closing our pending merger transactions, expected to begin during the second quarter.”